Results 291 to 300 of about 105,286 (352)

Regenerative Medicine Advancements: A Systematic Review on the Combinatory Effect of Platelet‐Rich Plasma/Fibrin and Collagen

International Journal of Biomaterials, Volume 2026, Issue 1, 2026.
Background The regeneration of injured tissues remains a major clinical challenge. Among emerging biomaterials, collagen with platelet‐rich plasma (PRP) or platelet‐rich fibrin (PRF) showed promising outcomes, individually and in combination. Objective To systematically review clinical evidence on the efficacy, applications, and safety of PRP/PRF and ...
Nunzia Gallo, Chiara Kodra, Domenico Rocco, Cosimo Saponaro, Alessandro Sannino, Luca Salvatore, Kai-Chiang Yang   +6 more
wiley   +1 more source

The P2X7 Receptor and Its Relation to Neglected Tropical Diseases: Focusing on Chagas Disease

Journal of Tropical Medicine, Volume 2026, Issue 1, 2026.
Chagas disease, caused by Trypanosoma cruzi, is a neglected tropical disease (NTD) that can lead to severe cardiac complications, including chronic Chagas cardiomyopathy. While NTDs are caused by a variety of pathogens—such as protozoa, bacteria, viruses, and helminths, Chagas disease remains underexplored, particularly regarding host immune responses.
Caroline de Souza Ferreira Pereira, Robson Xavier Faria, Wei Wang   +2 more
wiley   +1 more source

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu, Jing Wang, Qingshui Li, Danbo Wang, Cuiying Zhang, Junying Tang, Guonan Zhang, Min Hao, Desheng Yao, Qinglei Gao, Youzhong Zhang, Ruifang An, Rutie Yin, Li Wang, Bairong Xia, Qi Zhou, Hongying Yang, Jianqing Zhu, Kui Jiang, Zhengzheng Chen, Qiang Wu, Wei Duan, Yi Huang, Hui Zhang, Shuqing Wei, Guiling Li, Yuanguang Meng, Ke Wang, Xinfeng Yang, Xianghua Huang, Lingya Pan, Jinjin Yu, Ge Lou, Yu Zhang, Huaijun Zhou, Xiaoqing Guo, Hong Yang, Xiaodong Cheng, Xiumin Li, Wuliang Wang, Hongqin Zhao, Yunxia Li, Yingjie Yang, An Lin, Wenjun Cheng, Lihong Chen, Xiaoying Xie, Wen Di, Yuanjing Hu, Mo Chen, Hongwu Wen, Liping Cai, Xiaohua Wu, Zhongqiu Lin, Quanren Wang, Xinfeng Yang, Ning Li   +56 more
wiley   +1 more source

Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016.

JAMA Intern Med, 2018
Dayoub EJ, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Giri J, Groeneveld PW.   +6 more
europepmc   +1 more source

Structural flexibility of the nicotinamide group of NADH in butanol dehydrogenase YqdH from Fusobacterium nucleatum. [PDF]

PLoS One
Bai X, Nam KH, Xu Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The pyrophosphorylysis of adenosine diphosphate glucose and adenosine diphosphate mannose

Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 1964
Abstract 1. 1. The biosynthesis of adenosine diphosphate glucose and adenosine diphosphate mannose from adenosine triphosphate and respectively glucose 1-phosphate and mannose 1-phosphate has been observed in extracts from mammalian tissues. The reaction is reversible in the presence of the nucleoside diphosphate sugar and pyrophosphate. 2. 2.
H, VERACHTERT, S T, BASS, R G, HANSEN
openaire   +2 more sources

Adenosine diphosphate and adenosine monophosphate: enzymatic spectrophotometric determination

The Journal of Nutritional Biochemistry, 1990
Determination enzymatique et spectrophotometrique de l'adenosine diphosphate (ADP) et de l'adenosine monophosphate (AMP). Phosphorylation de l'ADP par une pyruvate kinase puis reduction du pyruvate en presence de NADH. Mesure de la consommation de NADH au spectrophotometre a 340 nm.
K, Tornheim, V, Schultz
openaire   +2 more sources

Poly(adenosine diphosphate ribose)

1982
Publisher Summary This chapter discusses the higher-order structure of poly(adenosine diphosphate ribose) [poly(ADPR)], poly(ADPR) polymerase purification and its properties, and molecular mechanisms of histone- and elongation-factor (EF-2)-ADP-ribosylation.
P, Mandel, H, Okazaki, C, Niedergang
openaire   +2 more sources